Cite
APA Citation
Sano, T., Terai, Y., Daimon, A., Nunode, M., Nagayasu, Y., Okamoto, A., Fujita, D., Hayashi, M., & Ohmichi, M. (2018). recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency – The leading cause of preeclampsia. Placenta, 65, 1–6. http://access.bl.uk/ark:/81055/vdc_100066136210.0x000047